Page last updated: 2024-09-05

sibenadet and indacaterol

sibenadet has been researched along with indacaterol in 3 studies

Compound Research Comparison

Studies
(sibenadet)
Trials
(sibenadet)
Recent Studies (post-2010)
(sibenadet)
Studies
(indacaterol)
Trials
(indacaterol)
Recent Studies (post-2010) (indacaterol)
2776309101250

Protein Interaction Comparison

ProteinTaxonomysibenadet (IC50)indacaterol (IC50)
Beta-1 adrenergic receptorHomo sapiens (human)0.3162
Beta-2 adrenergic receptorCavia porcellus (domestic guinea pig)0.0079

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alcaraz, L; Bailey, A; Cadogan, E; Connolly, S; Dainty, I; Jewell, R; Jordan, S; Kindon, N; Lawson, M; Lister, A; Mullen, A; Nicholls, D; Paine, S; Pairaudeau, G; Stocks, MJ; Thorne, P; Young, A1
Beattie, D; Beer, D; Bradley, ME; Bruce, I; Charlton, SJ; Cuenoud, BM; Fairhurst, RA; Farr, D; Fozard, JR; Janus, D; Rosethorne, EM; Sandham, DA; Sykes, DA; Trifilieff, A; Turner, KL; Wissler, E1
Alcaraz, L; Bailey, A; Bonnert, R; Cadogan, E; Christie, J; Connolly, S; Cook, A; Dixon, J; Fisher, A; Flaherty, A; Humphries, A; Ingall, A; Jordan, S; Lawson, M; Mullen, A; Nicholls, D; Paine, S; Pairaudeau, G; Stocks, MJ; Young, A1

Other Studies

3 other study(ies) available for sibenadet and indacaterol

ArticleYear
From libraries to candidate: the discovery of new ultra long-acting dibasic β₂-adrenoceptor agonists.
    Bioorganic & medicinal chemistry letters, 2012, Jan-01, Volume: 22, Issue:1

    Topics: Adrenergic beta-Agonists; Animals; Asthma; Bronchodilator Agents; Cell Line, Tumor; Chemistry, Pharmaceutical; Cyclic AMP; Drug Design; Guinea Pigs; Humans; Inhibitory Concentration 50; Models, Chemical; Protein Binding; Pulmonary Disease, Chronic Obstructive; Thiazoles; Time Factors

2012
An investigation into the structure-activity relationships associated with the systematic modification of the β(2)-adrenoceptor agonist indacaterol.
    Bioorganic & medicinal chemistry letters, 2012, Oct-01, Volume: 22, Issue:19

    Topics: Adrenergic beta-2 Receptor Agonists; Dose-Response Relationship, Drug; Humans; Indans; Molecular Structure; Quinolones; Receptors, Adrenergic, beta-2; Structure-Activity Relationship

2012
Discovery of AZD3199, An Inhaled Ultralong Acting β2 Receptor Agonist with Rapid Onset of Action.
    ACS medicinal chemistry letters, 2014, Apr-10, Volume: 5, Issue:4

    Topics:

2014